Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Effects of exercise training on nigrostriatal neuroprotection in Parkinson's disease: a systematic review
Ishaq S, Shah IA, Lee S-D, Wu B-T
Frontiers in Neuroscience 2024 Jan 8;18(1464168):Epub
systematic review

INTRODUCTION: Parkinson's disease (PD) is characterized by progressive neurodegeneration within the nigrostriatum, leading to motor dysfunction. This systematic review aimed to summarize the effects of various exercise training regimens on protein or gene expression within the nigrostriatum and their role in neuroprotection and motor function improvement in animal models of Parkinson's disease (PD). METHODS: PubMed, EMBASE, and Web of Science were searched up to June 2024 and included sixteen studies that adhere to PRISMA guidelines and CAMARADES checklist scores ranging from 4 to 6 out of 10. Various exercise training regimens, administered 5 days per week for 6.5 weeks, were applied to MPTP, 6-OHDA, and PFF-alpha-synuclein-induced PD animal models. RESULTS: Exercise training was found to downregulate the inflammatory pathway by attenuating alpha-synuclein aggregation, inhibiting the TLR/MyD88/IkappaBalpha signaling cascade and NF-kappaB phosphorylation, and decreasing pro-inflammatory cytokines IL-1beta and TNF-alpha while increasing anti-inflammatory cytokines IL-10 and TGF-beta within the nigrostriatum. It also inhibited the ASC and NLRP3 inflammasome complex and reduced the BAX/ Bcl-2 ratio and caspase-1/3 proteins, thereby decreasing neuronal apoptosis in the nigrostriatum. Exercise training elevated the expression of Pro-BDNF, BDNF, GDNF, TrkB, and Erk1/2, providing neurotrophic support to dopaminergic neurons. Furthermore, it upregulated the dopaminergic signaling pathway by increasing the expression of TH, DAT, PSD-95, and synaptophysin in the nigrostriatum. DISCUSSIONS: The findings suggested that exercise training downregulated inflammatory and apoptotic pathways while upregulated BDNF/GDNF pathways and dopaminergic signaling within the nigrostriatum. These molecular changes contributed to neuroprotection, reduced dopaminergic neuron loss, and improved motor function in PD animal models. SYSTEMATIC REVIEW REGISTRATION: CRD42024484537 https://www.crd.york.ac.uk/prospero/#recordDetails.

Full text (sometimes free) may be available at these link(s):      help